Concepedia

Publication | Closed Access

Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment?

DOI

90

Citations

16

References

1999

Year

Bernard Escudier, Christine Chevreau, Christine Lasset, Jean-Yves Douillard, Alain Ravaud, Michel Fabbro, Armelle Caty, Jean François Rossi, Patrice Viens, J.P. Bergerat,
Journal of Clinical Oncology

Abstract

Cross-over after failure of IL-2 or IFNalpha2a is poorly efficient in metastatic renal cell carcinoma, especially when progression has been clearly documented.

References

YearCitations

Page 1